A+ R A-

Monoclonal Antibody Therapy - Predictive Factors and Observations

Please select from the following list of abstracts, representing the presentations given in Paris 2004 (IWWM-3) Session 8:

Predictive Factors for Response to Rituximab in Waldenstrom's Macroglobulinemia. M.A. Dimopoulos, K. Zervas, D. Gika, A. Zomas, M.C. Kyrtsonis, A. Anagnostopoulos, N. Anagnostopoulos, G. Pangalis.

Polymorphisms In Fcriiia (CD16) Receptor Expression Are Associated With Clinical Response To Rituximab In Waldenstrom’s Macroglobulinemia. S. P. Treon, M. Hansen, A. Branagan, C. Emmanouilides, E. Kimby, S. Frankel, N. Touroutoglou, D. Maloney, K. C. Anderson, E. A. Fox.

The Initial “Flare”Of Igm Level After Rituximab Therapy In Patients Diagnosed With Waldenstrom Macroglobulinemia. Irene M Ghobrial, Rafael Fonseca, Philip R Greipp, Emily Blood, Montserrat Rue, David H Vesole, Morie A Gertz.

Paradoxical Increases In Serum Igm And Viscosity Levels Following Rituximab In Waldenstrom’s Macroglobulinemia. Andrew Branagan, Zachary Hunter, Daniel Ditzel Santos, Olivier Tournilhac, Robert Manning, and Steven P. Treon.